BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10037054)

  • 1. Lymphomatoid granulomatosis following autologous stem cell transplantation.
    Fassas A; Jagannath S; Desikan KR; Shah HR; Shaver R; Waldron J; Munshi NC; Barlogie B; Tricot G
    Bone Marrow Transplant; 1999 Jan; 23(1):79-81. PubMed ID: 10037054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary and isolated cutaneous lymphomatoid granulomatosis following heart-lung transplantation].
    Tas S; Simonart T; Dargent J; Kentos A; Antoine M; Knoop C; Estenne M; De Dobbeleer G
    Ann Dermatol Venereol; 2000 May; 127(5):488-91. PubMed ID: 10863178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection.
    Myers JL; Kurtin PJ; Katzenstein AL; Tazelaar HD; Colby TV; Strickler JG; Lloyd RV; Isaacson PG
    Am J Surg Pathol; 1995 Nov; 19(11):1300-12. PubMed ID: 7573693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient.
    Lones MA; Kirov I; Said JW; Shintaku IP; Neudorf S
    Bone Marrow Transplant; 2000 Nov; 26(9):1021-4. PubMed ID: 11100284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b.
    Wilson WH; Kingma DW; Raffeld M; Wittes RE; Jaffe ES
    Blood; 1996 Jun; 87(11):4531-7. PubMed ID: 8639820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of EBV-associated lymphoproliferative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation.
    Peniket AJ; Perry AR; Williams CD; MacMillan A; Watts MJ; Isaacson PG; Goldstone AH; Linch DC
    Bone Marrow Transplant; 1998 Aug; 22(3):307-9. PubMed ID: 9720750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
    Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
    Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E; Cornelissen JJ
    Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
    J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation.
    Kiel K; Cremer FW; Rottenburger C; Kallmeyer C; Ehrbrecht E; Atzberger A; Hegenbart U; Goldschmidt H; Moos M
    Bone Marrow Transplant; 1999 May; 23(10):1019-27. PubMed ID: 10373068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A solitary pulmonary lymphomatoid granulomatosis-like lesion as the only manifestation of post-transplant lymphoproliferative disorder after hematopoietic stem-cell transplantation.
    Yang SH; Yeh YC; Chan YJ; Chou TY; Hsiao LT
    Ann Hematol; 2011 Dec; 90(12):1481-3. PubMed ID: 21365269
    [No Abstract]   [Full Text] [Related]  

  • 16. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity.
    Peggs KS; Mackinnon S; Williams CD; D'Sa S; Thuraisundaram D; Kyriakou C; Morris EC; Hale G; Waldmann H; Linch DC; Goldstone AH; Yong K
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):257-65. PubMed ID: 12720218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary lymphomatoid granulomatosis in a renal allograft recipient.
    Joseph R; Chacko B; Manipadam MT; Sureka J; Cherian VK; John GT
    Transpl Infect Dis; 2008 Feb; 10(1):52-5. PubMed ID: 17511820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.